2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivoXueyin Zu, Dong Joon Kim|Journal of Experimental & Clinical Cancer Research|2020Cited by 21
OSGIN1 is a novel TUBB3 regulator that promotes tumor progression and gefitinib resistance in non-small cell lung cancerXiaomeng Xie, Dong Joon Kim|Cellular and Molecular Life Sciences|2023Cited by 18